Fundraising Overview - The company raised a total of RMB 1,400,732,340.85 through its initial public offering, with the funds deposited in a designated account on December 16, 2021 [1] - As of June 30, 2025, the company has utilized RMB 573,704,200.00 of the raised funds, with RMB 46,799,400.00 used in the current year, all allocated to fundraising projects [1][2] - The remaining balance of the raised funds is RMB 935,461,000.00, which includes RMB 108,432,900.00 in net interest income after deducting fees [1] Fund Management - The company has established a fundraising management system to ensure compliance with regulatory requirements and protect investor interests, which was approved by the board on July 25, 2020 [1] - The company has signed a tripartite supervision agreement with its sponsor and a local bank to enhance the management and efficiency of the raised funds [1][2] Fund Usage and Adjustments - The company has reported that there are no fundraising projects that cannot be individually accounted for in terms of benefits [2] - The company has adjusted its fundraising usage plan, reallocating funds from the "annual production of 1,200 tons of raw materials project" to the "high-end pharmaceutical formulation internationalization project," with a total investment of RMB 33,227,000.00 planned for the latter [3][4] - The company has decided to terminate the "annual production of 5,000 tons of ibuprofen raw materials project" due to market saturation and price decline, reallocating the remaining funds to other projects [3][5] Project Progress and Timeline - The two fundraising projects, "annual production of 700 tons of raw materials project" and "annual production of 12 tons of anti-tumor raw materials project," are expected to reach usable status by December 2024, with ongoing construction and testing [3][5] - The "high-end pharmaceutical formulation internationalization project" is also facing delays, with an expected completion date extended to December 2026 due to regulatory and market factors [3][4]

Core Viewpoint - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss adjustments to fundraising project investments and the use of excess funds raised from its initial public offering [5][12]. Meeting Procedures - The company has established guidelines for the meeting to ensure the rights of shareholders are protected and to facilitate orderly proceedings [1][2]. - Shareholders must register and present identification documents before the meeting starts, and latecomers will not be allowed to vote [2][3]. - The meeting will follow a predetermined agenda, allowing shareholders to express their opinions and vote on various proposals [2][4]. Fundraising Overview - The company successfully raised a total of RMB 87,598.50 million from its initial public offering, with a net amount of RMB 78,781.67 million after deducting issuance costs [5][6]. - The funds have been deposited in a dedicated account, and a tripartite supervision agreement has been signed with the underwriter and the bank [6][7]. Project Investment Adjustments - The company plans to adjust the investment amounts and internal structure of certain fundraising projects, including the "Distributed Fiber Optic Sensing System Upgrade R&D and Production Project" and the "Asset Digital Operation and Maintenance Platform R&D Project" [8][10]. - The total investment for the "Distributed Fiber Optic Sensing System Upgrade R&D and Production Project" will increase from RMB 30,908.93 million to RMB 33,650.12 million [10]. - The "Asset Digital Operation and Maintenance Platform R&D Project" will see its investment rise from RMB 8,000.28 million to RMB 9,221.58 million [10]. Impact of Adjustments - The adjustments to the investment amounts and the use of excess funds are intended to enhance the efficiency of fund utilization and optimize resource allocation, aligning with the company's long-term strategic goals [10][11]. - The company asserts that these changes will not adversely affect its normal operations or harm the interests of shareholders [10][11].

长江证券承销保荐有限公司 关于西安西测测试技术股份有限公司 调整部分募投项目内部结构及实施地点的核查意见 长江证券承销保荐有限公司（以下简称"长江保荐"或"保荐机构"）作为西安 西测测试技术股份有限公司（以下简称"西测测试"或"公司"）首次公开发行股票 并在创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证 券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号 ——创业板上市公司规范运作》《上市公司监管指引第 2 号——上市公司募集资 《深圳证券交易所上市公司自律监管指引第 13 号—— 金管理和使用的监管要求》 保荐业务》等相关法律、法规和规范性文件的规定，对西测测试调整部分募投项 目内部结构及实施地点的事项进行了审慎核查，核查情况及意见如下： 一、募集资金基本情况 经中国证券监督管理委员会（以下简称"中国证监会"） 《关于同意西安西测 （证监许可【2022】748 号） 测试技术股份有限公司首次公开发行股票注册的批复》 为规范公司募集资金管理，保护投资者权益，公司及公司控股子公司与保荐 人、募集资金专户开户银行签署了《募集资金三方/四方监管协议》，开设了募集 资金专项 ...

Core Viewpoint - The report provides a comprehensive overview of the fundraising activities and the utilization of funds by Shanghai Aiwei Electronics Technology Co., Ltd. as of June 30, 2025, ensuring compliance with regulatory guidelines and reflecting the company's financial management practices [1][3]. Fundraising Overview - The total amount raised through the public offering was RMB 3,201,044,000, with a net amount of RMB 3,035,261,414 after deducting issuance costs [3]. - The funds were deposited into a designated bank account, with specific details on the account balances and management practices outlined [3]. Fund Utilization - As of June 30, 2025, the company had utilized RMB 2,165,506,800, accounting for 71.34% of the net fundraising amount, with a remaining balance of RMB 984,051,900 [12]. - The company adjusted the investment amount for the "R&D Center Construction Project" from RMB 408.25 million to RMB 218.92 million, reallocating the remaining funds to the "Electronic Engineering Testing Center Construction Project" [4]. Temporary Fund Management - The company approved the temporary use of idle funds, allowing up to RMB 780 million for operational needs, which was fully returned by August 22, 2022 [5]. - A subsequent approval allowed for the use of up to RMB 600 million in idle funds, which was also returned by August 15, 2024 [6][8]. Cash Management - The company engaged in cash management activities, utilizing idle funds for purchasing low-risk financial products, with a total of RMB 250 million allocated for such investments as of June 30, 2025 [12][10]. Project Adjustments and Economic Benefits - The company has made adjustments to project timelines, extending the expected completion date for the "Electronic Engineering Testing Center Construction Project" from August 2024 to March 2026 [4]. - Several projects, including the R&D Center and various chip development initiatives, are still under construction and do not yet generate direct economic benefits [18]. Compliance and Reporting - The report confirms that the actual use of funds aligns with previously disclosed information, ensuring transparency and adherence to regulatory requirements [19].

Core Viewpoint - The company announced adjustments and delays to certain fundraising projects to improve the efficiency of fundraising usage while keeping the total amount unchanged [1][2]. Fundraising Basic Situation - The company raised a total of RMB 3,201,044,000 from its initial public offering, with a net amount of RMB 3,201,044,000 after deducting issuance costs [1]. Fundraising Investment Project Situation - The total investment amount for the projects is RMB 246,813.72 million, with the company planning to use the remaining over-raised funds of RMB 47,220.00 million for new projects [2]. - The company decided to allocate approximately RMB 20,183.60 million from remaining funds to the "Electronic Engineering Testing Center Construction Project," increasing its total investment from RMB 73,858.20 million to RMB 94,041.80 million [2]. Fundraising Usage Situation - As of June 30, 2025, the cumulative investment amount reached RMB 294,561.17 million, with RMB 206,546.28 million from the raised funds [4]. Adjustment of Fundraising Project Sub-items - The company adjusted the investment amounts for several projects, including increasing the investment for high-voltage BCD advanced process from RMB 6,500 million to RMB 14,000 million [4]. - The investment for the RiscV architecture SoC platform was reduced from RMB 4,800 million to RMB 2,000 million due to market conditions [4]. Delay of Fundraising Projects - The company plans to delay the expected completion date for the "Development and Technology Reserve Fund Project" from August 2025 to August 2026 [6]. - The delay is attributed to changes in the macro market environment, industry technology development, and the company's strategic adjustments [6]. Measures to Ensure Timely Completion - The company will closely monitor industry trends and market changes, optimize resource allocation, and strengthen project supervision to ensure timely completion of fundraising projects [7]. Impact of Project Delay - The delay is a prudent decision based on actual project progress and will not adversely affect the implementation of fundraising projects or harm shareholder interests [7][8].

Core Viewpoint - The company has completed the conclusion of certain fundraising projects and plans to permanently supplement its working capital with the remaining funds, while also terminating some fundraising projects and continuing to manage the remaining funds in a dedicated account [2][10]. Fundraising Basic Situation - The company raised a total of RMB 161,846.38 million from its initial public offering, with a net amount of RMB 153,596.90 million after deducting issuance costs [2][3]. - As of June 30, 2025, the company has invested RMB 101,216.57 million, representing 65.90% of the committed investment [3]. Fundraising Project Status - The "East China R&D and Technical Service Center Construction Project" has been concluded, with remaining funds of RMB 3,211.84 million to be used for working capital after settling outstanding payments [5][10]. - The "East China Machine Vision Industrial Park Construction Project" has been terminated due to delays in obtaining necessary permits and changes in market demand, with a total planned investment of RMB 30,659.78 million [5][10]. Project Termination Reasons - The termination of the "East China Machine Vision Industrial Park Construction Project" is attributed to the expansion of downstream product demand beyond the original project scope and the company's comprehensive product line upgrade [9][10]. - The project was initially planned to meet specific market needs, but the evolving market landscape has necessitated a reevaluation of the project’s viability [9][10]. Future Plans - The company intends to seek new investment projects while continuing to evaluate existing projects for potential additional investments [10]. - The remaining funds from the terminated project will continue to be managed in accordance with fundraising management requirements [10]. Internal Review Process - The board of directors and the supervisory board have approved the conclusion of certain fundraising projects and the management of remaining funds, ensuring compliance with relevant regulations [11][12]. Sponsor Institution Opinion - The sponsor institution supports the company's decisions regarding the conclusion and management of fundraising projects, affirming that these actions align with the company's operational realities and long-term strategy [12][13].

Meeting Details - The second meeting of the Supervisory Board of Suzhou Guangge Technology Co., Ltd. was held on July 23, 2025, with all three supervisors present, confirming the legality and validity of the meeting [1]. Cash Management Decisions - The Supervisory Board approved the use of up to RMB 280 million of temporarily idle raised funds for cash management, which is in compliance with relevant regulations and aims to enhance fund utilization efficiency and increase returns for the company and its shareholders [1]. - The Board also agreed to use up to RMB 150 million of temporarily idle self-owned funds for cash management, emphasizing that this will not adversely affect the company's normal operations or the interests of shareholders, particularly minority shareholders [2]. Adjustments to Investment Projects - The Supervisory Board consented to adjustments in the investment amounts and internal structure of certain fundraising projects, stating that these changes are based on objective circumstances and will not negatively impact the implementation of fundraising projects or the company's normal operations [3]. - This adjustment will be submitted for approval at the shareholders' meeting, with the Board affirming that it does not constitute a substantive change in the use of raised funds or harm shareholder interests [3].

Group 1 - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss various proposals, including the extension, termination, and addition of implementation content for fundraising projects [1][7] - The meeting will take place on July 29, 2025, at 14:00 in the company's conference room, with both on-site and online voting options available [6][14] - Shareholders and their representatives are required to register 30 minutes before the meeting and must present identification to participate in the voting process [2][3] Group 2 - The company plans to adjust its fundraising project timelines due to market conditions, including a slowdown in the semiconductor market and changes in customer demand [11][12] - The company has decided to terminate the "High-Precision PGA/ADC Signal Chain Chip Upgrade and Industrialization Project" due to unfavorable market conditions and the need to allocate resources more effectively [20][21] - The remaining funds from the terminated project will be kept in a special account and used for new projects that align with the company's strategic goals [22][30] Group 3 - The company intends to increase the implementation content of the "R&D Center Construction Project" to enhance its capabilities in mixed-signal SoC chip products and applications [23][26] - The company is focusing on developing smart home control chips as part of its strategic deployment in response to market trends and government policies promoting smart home technologies [28][29] - The adjustments made to the project are expected to optimize resource allocation and ensure the smooth implementation of fundraising projects without negatively impacting the company's operations [29][30] Group 4 - The company is proposing changes to its registered capital and profit distribution policy, as well as the cancellation of the supervisory board, to align with its operational needs and legal requirements [30][31] - The registered capital will be adjusted following the completion of the 2023 restricted stock incentive plan, increasing the total share capital significantly [31]

华泰联合证券有限责任公司 关于华电新能源集团股份有限公司 使用募集资金置换预先投入募投项目自筹资金、募投项目 实施主体调整及募投金额分配额度确认的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐机 构"）作为华电新能源集团股份有限公司（以下简称"华电新能"、"公司" 或"发行人"）首次公开发行股票并在主板上市的联席保荐机构，根据《证券 发行上市保荐业务管理办法》《上市公司募集资金监管规则》《上海证券交易 所股票上市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运 作》等法律法规的规定，对华电新能使用募集资金置换预先投入募投项目自筹 资金、募投项目实施主体调整及募投金额分配额度确认的事项进行审慎核查， 具体核查情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会 2025 年 5 月 16 日核发的《关于同意华电新 能源集团股份有限公司首次公开发行股票注册的批复》（证监许可〔2025〕 券交易所上市（以下简称"本次发行"）。本次发行的发行价格为 3.18 元/股， 本次发行募集资金总额 15,801,242,600.52 元（超额配售选择权行使前），扣减 发行费用（不含 ...

Core Viewpoint - The company is convening the first bondholders' meeting for the "Haiyou Convertible Bonds" in 2025 to discuss the termination of certain fundraising projects and the reallocation of remaining funds to new projects, which is seen as a strategic decision to enhance operational efficiency and align with market demands [7][8]. Meeting Procedures - The meeting will ensure the legal rights of all bondholders and maintain order, allowing only authorized participants to attend [1][2]. - Bondholders must sign in and present necessary documentation to participate in the meeting [2][3]. - The meeting will follow a structured agenda, including the announcement of attendees and their voting rights [5][7]. Agenda Items - The primary agenda item is the proposal to terminate the "Annual Production of 200 Million Square Meters of Photovoltaic Packaging Glue Film Project (Phase I)" and redirect the remaining funds to a new project for "Annual Production of 2 Million Square Meters of PDCLC Light Control Film Products (Phase I)" with an investment scale of 250 million yuan [7][8]. - The decision to terminate the previous project and initiate a new one is based on market conditions and the company's strategic development plan [8]. Voting and Rights - Bondholders will have the right to express their opinions and vote on the proposals, with each bond representing one vote [4][6]. - The meeting will utilize both on-site and remote voting methods, ensuring transparency and accountability in the decision-making process [4][5].